Grant Avenue Capital

Bobby Sharma, the Founder and Managing Partner, leads investment decisions for the firm. He established Grant Avenue after serving as a partner at BlueMountain Capital Management, where he co-led the healthcare private equity strategy. His prior experience also includes a tenure at The Carlyle Group, giving him a background in both operationally focused and large-scale private equity investing.

The firm pursues control-oriented buyouts, corporate divestitures, and founder recapitalizations exclusively within the healthcare sector. It focuses on the lower middle market, targeting outsourced pharmaceutical services, multi-site healthcare provider platforms, and technology-enabled care models. The strategy emphasizes post-acquisition operational engagement and management partnership rather than financial engineering.

Its single-sector commitment at the lower end of the middle market sets it apart. Generalist small-cap funds often compete for healthcare deals without dedicated domain expertise or operational playbooks, while large healthcare private equity platforms concentrate on bigger targets. Grant Avenue occupies the intersection, providing the domain depth of a specialist with a mandate sized for founder- and family-owned companies.

The firm's investment activity has been concentrated in North America, with a primary emphasis on businesses headquartered in the United States. There is no public evidence of completed platform investments in Europe, Asia, or other regions. Its sourcing and operational model is built around domestic healthcare services and outsourcing companies.

Yes. In September 2023, the firm completed a final close on its debut institutional fund (per PE Hub, 2023). This marked a transition from a flexible, deal-by-deal capital model to a more traditional private equity fund structure with limited partners and a commitment period.